05
2026 06
2026 ASCO Panorama In-Depth Interpretation | Organoids Enter the First Year of Clinical Implementation, Moving from Laboratory Drug Susitivity to Standardized and Precise Tumor Diagnosis and Treatment
03
2026 06
FDA New Policy Implemented: Organoids Officially Enter the Main Oncology Drug Review Track, and Animal Testing Is No Longer the Only Path
02
2026 06
Empowered by medical insurance, the organoid and organ-on-a-chip industries are about to explode
19
2026 05
The Central Inspection Institute is laying out innovative evaluation—new opportunities for the organoid and organ-on-a-chip industry
09
2026 05
The Organoid Industry's Time Gamble: The Final Game of Two Technical Routes
24
2026 04
Animal Experiment Reduction in Drug Development: FDA Releases First Year Results Report
12
2025 12
The annual research focus announced! Why did organoids and organ chips make it into the annual Review?
24
2025 11
Fuyou Life is participating in the compilation! The group standard for vascularized organoids has been officially released, marking a new level of industry standardization and development
